Last reviewed · How we verify
Chlorure de sodium — Competitive Intelligence Brief
phase 3
Electrolyte replacement agent
Electrolyte/Fluid Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Chlorure de sodium (Chlorure de sodium) — Centre Hospitalier Universitaire Dijon. Sodium chloride replaces lost electrolytes and restores osmotic balance in body fluids.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chlorure de sodium TARGET | Chlorure de sodium | Centre Hospitalier Universitaire Dijon | phase 3 | Electrolyte replacement agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Electrolyte replacement agent class)
- Centre Hospitalier Universitaire Dijon · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chlorure de sodium CI watch — RSS
- Chlorure de sodium CI watch — Atom
- Chlorure de sodium CI watch — JSON
- Chlorure de sodium alone — RSS
- Whole Electrolyte replacement agent class — RSS
Cite this brief
Drug Landscape (2026). Chlorure de sodium — Competitive Intelligence Brief. https://druglandscape.com/ci/chlorure-de-sodium. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing